Benzodiazepines: Risks and benefits. A reconsideration

David S. Baldwin(University of Southampton), Sue Wilson(Imperial College London), H. Valerie Curran(MRC Cancer Unit), Katherine J. Aitchison(University of Alberta), David Stephens(Anglia Ruskin University), Alan N. Bateson(Dominica State College), David Nutt(Imperial College London), Brian E. Leonard(Michigan State University), Simon Davies(Centre for Addiction and Mental Health)
Journal of Psychopharmacology
September 24, 2013
10.1177/0269881113503509
Cited by 236

Related Papers

International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function.
|PubMed|1998|1.2k
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
|Psychopharmacology|2017|969
Neural correlates of the LSD experience revealed by multimodal neuroimaging
|Proceedings of the National Academy of Sciences|2016|880
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
|JAMA Psychiatry|2016|856
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653